Elizabeth Czerepak
2012 - Cancer Genetics
In 2012, Elizabeth Czerepak earned a total compensation of $325K as Chief Financial Officer at Cancer Genetics.
Compensation breakdown
| Bonus | $75,000 |
|---|---|
| Salary | $250,000 |
| Total | $325,000 |
Czerepak received $250K in salary, accounting for 77% of the total pay in 2012.
Czerepak also received $75K in bonus.
Rankings
In 2012, Elizabeth Czerepak's compensation ranked 9,954th out of 11,487 executives tracked by ExecPay. In other words, Czerepak earned more than 13.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,954 out of 11,487 | 13th |
Division Services | 1,499 out of 1,721 | 13th |
Major group Health Services | 154 out of 167 | 8th |
Industry group Medical And Dental Laboratories | 38 out of 41 | 7th |
Industry Medical Laboratories | 38 out of 41 | 7th |
Source: SEC filing on April 21, 2014.
Czerepak's colleagues
We found two more compensation records of executives who worked with Elizabeth Czerepak at Cancer Genetics in 2012.